Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic Malignancy
Clinical trial NCT05860075 · TERMINATED
Trial details
- NCT number
- NCT05860075
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-19
- Primary completion
- 2022-10-26
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.